
Total amount raised
$133.5M
Latest funding date
2026-01-22

Location
Qure AI has successfully raised funding through four rounds, with the most recent being a Series D round involving seven investors, including 360 ONE Asset and Lightspeed Venture Partners. The company specializes in AI-driven healthcare solutions, focusing on areas such as tuberculosis, lung cancer, and stroke care.
What Is Qure AI?
Qure AI, founded in 2016, is a healthcare technology company based in Andheri, Maharashtra, India. Specializing in AI-driven healthcare solutions, the company focuses on automated interpretation of radiology exams and ultrasound scans.
Operating in industries such as Artificial Intelligence, Health Care, Health Diagnostics, Machine Learning, and Medical Device, Qure AI has a workforce of 251-500 employees. The company has made a significant impact, with its technology being adopted in over 105 countries and affecting more than 40 million lives.
How Much Funding Has Qure AI Raised?
- Venture Round
- Amount Raised: USD 16,000,000
- Date: February 2020
- Lead Investors: Peak XV Partners (formerly Sequoia India)
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To further develop AI technology and expand market presence.
- Grant
- Amount Raised: USD 4,330,000
- Date: February 2022
- Lead Investors: SBRI Healthcare
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support development of AI-powered cancer detection solutions for the NHS.
- Series C
- Amount Raised: USD 40,000,000
- Date: March 2022
- Lead Investors: Novo Holdings, HealthQuad
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To bolster presence in the US and Europe and enhance product development for critical care and community diagnostics. TEAMFund LP subsequently joined this round as an additional investor.
- Series D
- Amount Raised: USD 65,000,000
- Date: September 2024
- Lead Investors: Lightspeed Venture Partners, 360 ONE Asset
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand global healthcare AI presence, invest in AI model development, and grow into new markets. New investors Merck Global Health Innovation Fund and Kae Capital also participated, alongside existing investors Novo Holdings, HealthQuad, and TEAMFund.
- Grant
- Amount Raised: USD 8,168,624
- Date: January 2026
- Lead Investors: Bill & Melinda Gates Foundation
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To develop AI-enabled point-of-care ultrasound algorithms for early detection of TB and pneumonia, and to build a large open-source multi-modal database for lung health diagnostics.
Total Amount Raised: At least USD 133,498,624 based on disclosed funding. Current Valuation: Not publicly disclosed.
Key Investors
- Bill & Melinda Gates Foundation
- Details: The Bill & Melinda Gates Foundation is one of the world's largest private charitable foundations, focused on global health and development. Their January 2026 grant to Qure AI supports AI-powered point-of-care ultrasound development for low- and middle-income countries.
- Investment Focus Areas: Global health, infectious disease, diagnostics, and development.
- Notable Investments: Grants to hundreds of global health organizations and research institutions.
- Lightspeed Venture Partners
- Details: Lightspeed Venture Partners is a global venture capital firm focusing on early and growth-stage investments. They co-led Qure AI's $65M Series D in September 2024.
- Investment Focus Areas: Technology, consumer, and enterprise sectors.
- Notable Investments: Snap, Grubhub, Affirm.
- 360 ONE Asset
- Details: Also known as IIFL Asset Management, 360 ONE Asset is a leading asset management company. They co-led Qure AI's Series D alongside Lightspeed in September 2024.
- Investment Focus Areas: General asset management across various sectors.
- Notable Investments: Investments in various sectors including technology and healthcare.
- HealthQuad
- Details: HealthQuad is a healthcare-focused venture capital fund that invests in innovative healthcare companies. They aim to transform healthcare delivery through technology.
- Investment Focus Areas: Healthcare and life sciences.
- Notable Investments: Medikabazaar, THB (Technology Healthcare Big Data), ImpactGuru.
- Novo Holdings
- Details: Novo Holdings is a leading international life sciences investor. They manage the assets and wealth of the Novo Nordisk Foundation.
- Investment Focus Areas: Life sciences, healthcare, sustainable development.
- Notable Investments: Novozymes, Chr. Hansen, Xellia Pharmaceuticals.
- SBRI Healthcare
- Details: SBRI Healthcare is an initiative that provides funding to develop innovative solutions to healthcare challenges. They focus on supporting small and medium-sized enterprises.
- Investment Focus Areas: Healthcare innovation and technology.
- Notable Investments: Funding for healthcare innovation projects.
What's Next for Qure AI?
Qure AI is poised for significant growth, with opportunities to expand its presence in the US and Europe. The recent $40 million funding round will enable the company to enhance its AI-driven medical imaging diagnostics, making healthcare more accessible and efficient. This expansion is crucial as the demand for faster and more accurate diagnostic tools continues to rise globally.
Future fundraising opportunities appear promising, given the substantial backing from investors like Novo Holdings and HealthQuad. These funds will likely support further technological advancements and market penetration, positioning Qure AI as a leader in the AI healthcare sector. However, the company may face challenges such as navigating regulatory approvals and competing with other AI-driven health tech firms.
Use Clay to Get Funding Data
Sales professionals, leverage Clay's platform to access comprehensive fundraising data on companies like Qure AI and gather other critical business insights. Sign up for free to start transforming your sales strategy today.



















.png)








.png)









